A genetics-free method for high-throughput discovery of cryptic microbial metabolites

Fei Xu, Yihan Wu, Chen Zhang, Katherine M. Davis, Kyuho Moon, Leah B. Bushin, Mohammad R. Seyedsayamdost

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Bacteria contain an immense untapped trove of novel secondary metabolites in the form of ‘silent’ biosynthetic gene clusters (BGCs). These can be identified bioinformatically but are not expressed under normal laboratory growth conditions. Methods to access their products would dramatically expand the pool of bioactive compounds. We report a universal high-throughput method for activating silent BGCs in diverse microorganisms. Our approach relies on elicitor screening to induce the secondary metabolome of a given strain and imaging mass spectrometry to visualize the resulting metabolomes in response to ~500 conditions. Because it does not require challenging genetic, cloning, or culturing procedures, this method can be used with both sequenced and unsequenced bacteria. We demonstrate the power of the approach by applying it to diverse bacteria and report the discovery of nine cryptic metabolites with potentially therapeutic bioactivities, including a new glycopeptide chemotype with potent inhibitory activity against a pathogenic virus.

Original languageEnglish (US)
Pages (from-to)161-168
Number of pages8
JournalNature Chemical Biology
Volume15
Issue number2
DOIs
StatePublished - Feb 1 2019

Fingerprint

Metabolome
Multigene Family
Bacteria
Glycopeptides
Organism Cloning
Mass Spectrometry
Viruses
Growth
Therapeutics

Cite this

Xu, Fei ; Wu, Yihan ; Zhang, Chen ; Davis, Katherine M. ; Moon, Kyuho ; Bushin, Leah B. ; Seyedsayamdost, Mohammad R. / A genetics-free method for high-throughput discovery of cryptic microbial metabolites. In: Nature Chemical Biology. 2019 ; Vol. 15, No. 2. pp. 161-168.
@article{19ca88d35bb6474ca22e5f559857af25,
title = "A genetics-free method for high-throughput discovery of cryptic microbial metabolites",
abstract = "Bacteria contain an immense untapped trove of novel secondary metabolites in the form of ‘silent’ biosynthetic gene clusters (BGCs). These can be identified bioinformatically but are not expressed under normal laboratory growth conditions. Methods to access their products would dramatically expand the pool of bioactive compounds. We report a universal high-throughput method for activating silent BGCs in diverse microorganisms. Our approach relies on elicitor screening to induce the secondary metabolome of a given strain and imaging mass spectrometry to visualize the resulting metabolomes in response to ~500 conditions. Because it does not require challenging genetic, cloning, or culturing procedures, this method can be used with both sequenced and unsequenced bacteria. We demonstrate the power of the approach by applying it to diverse bacteria and report the discovery of nine cryptic metabolites with potentially therapeutic bioactivities, including a new glycopeptide chemotype with potent inhibitory activity against a pathogenic virus.",
author = "Fei Xu and Yihan Wu and Chen Zhang and Davis, {Katherine M.} and Kyuho Moon and Bushin, {Leah B.} and Seyedsayamdost, {Mohammad R.}",
year = "2019",
month = "2",
day = "1",
doi = "https://doi.org/10.1038/s41589-018-0193-2",
language = "English (US)",
volume = "15",
pages = "161--168",
journal = "Nature Chemical Biology",
issn = "1552-4450",
publisher = "Nature Publishing Group",
number = "2",

}

A genetics-free method for high-throughput discovery of cryptic microbial metabolites. / Xu, Fei; Wu, Yihan; Zhang, Chen; Davis, Katherine M.; Moon, Kyuho; Bushin, Leah B.; Seyedsayamdost, Mohammad R.

In: Nature Chemical Biology, Vol. 15, No. 2, 01.02.2019, p. 161-168.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A genetics-free method for high-throughput discovery of cryptic microbial metabolites

AU - Xu, Fei

AU - Wu, Yihan

AU - Zhang, Chen

AU - Davis, Katherine M.

AU - Moon, Kyuho

AU - Bushin, Leah B.

AU - Seyedsayamdost, Mohammad R.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Bacteria contain an immense untapped trove of novel secondary metabolites in the form of ‘silent’ biosynthetic gene clusters (BGCs). These can be identified bioinformatically but are not expressed under normal laboratory growth conditions. Methods to access their products would dramatically expand the pool of bioactive compounds. We report a universal high-throughput method for activating silent BGCs in diverse microorganisms. Our approach relies on elicitor screening to induce the secondary metabolome of a given strain and imaging mass spectrometry to visualize the resulting metabolomes in response to ~500 conditions. Because it does not require challenging genetic, cloning, or culturing procedures, this method can be used with both sequenced and unsequenced bacteria. We demonstrate the power of the approach by applying it to diverse bacteria and report the discovery of nine cryptic metabolites with potentially therapeutic bioactivities, including a new glycopeptide chemotype with potent inhibitory activity against a pathogenic virus.

AB - Bacteria contain an immense untapped trove of novel secondary metabolites in the form of ‘silent’ biosynthetic gene clusters (BGCs). These can be identified bioinformatically but are not expressed under normal laboratory growth conditions. Methods to access their products would dramatically expand the pool of bioactive compounds. We report a universal high-throughput method for activating silent BGCs in diverse microorganisms. Our approach relies on elicitor screening to induce the secondary metabolome of a given strain and imaging mass spectrometry to visualize the resulting metabolomes in response to ~500 conditions. Because it does not require challenging genetic, cloning, or culturing procedures, this method can be used with both sequenced and unsequenced bacteria. We demonstrate the power of the approach by applying it to diverse bacteria and report the discovery of nine cryptic metabolites with potentially therapeutic bioactivities, including a new glycopeptide chemotype with potent inhibitory activity against a pathogenic virus.

UR - http://www.scopus.com/inward/record.url?scp=85059645289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059645289&partnerID=8YFLogxK

U2 - https://doi.org/10.1038/s41589-018-0193-2

DO - https://doi.org/10.1038/s41589-018-0193-2

M3 - Article

VL - 15

SP - 161

EP - 168

JO - Nature Chemical Biology

JF - Nature Chemical Biology

SN - 1552-4450

IS - 2

ER -